Citius Pharmaceuticals (CTXR) PT Raised to $10 at Dawson James
Tweet
Share
E-mailGet Alerts CTXR Hot Sheet
Price: $0.56 --0%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 18
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 18
Join SI Premium – FREE
Dawson James analyst Jason Kolbert raised the price target on Citius Pharmaceuticals (NASDAQ: CTXR) to $10.00 (from $8.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Tohoku Electric Power Co Inc (9506:JP) PT Raised to JPY1,960 at Nomura/Instinet
- Affin Bank Bhd. (ABANK:MK) PT Lowered to MYR2.40 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
